Matches in SemOpenAlex for { <https://semopenalex.org/work/W3081209880> ?p ?o ?g. }
- W3081209880 endingPage "2363" @default.
- W3081209880 startingPage "2363" @default.
- W3081209880 abstract "Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively is able to increase apoptosis in cancer cells as agent with minimum toxicity to noncancerous cells. However, all cancer cells are not sensitive to TRAIL-induced apoptosis. In this study, we showed the sub-lethal concentrations of a lysosomotropic autophagy inhibitor, IITZ-01, sensitizes cancer cells (renal, lung, and breast carcinoma) to TRAIL-induced apoptosis through DR5 upregulation and survivin downregulation through ubiquitin-proteasome pathway. Knockdown of DR5 or overexpression of survivin inhibited combined treatment with IITZ-01 and TRAIL-induced apoptosis. IITZ-01 downregulated protein expression of Cbl, ubiquitin E3 ligase, and decreased expression level of Cbl markedly led to increase DR5 protein expression and TRAIL sensitivity. Moreover, IITZ-01 decreased expression level of survivin protein via downregulation of deubiquitinase ubiquitin-specific protease 9X (USP9X) expression. Taken together, these results provide the first evidence that IITZ-01 enhances TRAIL-mediated apoptosis through DR5 stabilization by downregulation of Cbl and USP9X-dependent survivin ubiquitination and degradation in renal carcinoma cells." @default.
- W3081209880 created "2020-09-01" @default.
- W3081209880 creator A5000050616 @default.
- W3081209880 creator A5023127914 @default.
- W3081209880 creator A5023771868 @default.
- W3081209880 creator A5026036097 @default.
- W3081209880 creator A5032767655 @default.
- W3081209880 creator A5042383220 @default.
- W3081209880 creator A5069526351 @default.
- W3081209880 creator A5070789043 @default.
- W3081209880 creator A5070894256 @default.
- W3081209880 date "2020-08-21" @default.
- W3081209880 modified "2023-10-13" @default.
- W3081209880 title "Upregulation of DR5 and Downregulation of Survivin by IITZ-01, Lysosomotropic Autophagy Inhibitor, Potentiates TRAIL-Mediated Apoptosis in Renal Cancer Cells via Ubiquitin-Proteasome Pathway" @default.
- W3081209880 cites W10640494 @default.
- W3081209880 cites W1863167619 @default.
- W3081209880 cites W1971576831 @default.
- W3081209880 cites W1975512999 @default.
- W3081209880 cites W1989847300 @default.
- W3081209880 cites W1990185188 @default.
- W3081209880 cites W1999041896 @default.
- W3081209880 cites W2000219934 @default.
- W3081209880 cites W2017593971 @default.
- W3081209880 cites W2021414407 @default.
- W3081209880 cites W2023131365 @default.
- W3081209880 cites W2049054723 @default.
- W3081209880 cites W2050776828 @default.
- W3081209880 cites W2058283739 @default.
- W3081209880 cites W2073788301 @default.
- W3081209880 cites W2074877259 @default.
- W3081209880 cites W2075482214 @default.
- W3081209880 cites W2079286948 @default.
- W3081209880 cites W2088183706 @default.
- W3081209880 cites W2090721555 @default.
- W3081209880 cites W2105186639 @default.
- W3081209880 cites W2139364069 @default.
- W3081209880 cites W2152462290 @default.
- W3081209880 cites W2154597953 @default.
- W3081209880 cites W2253837246 @default.
- W3081209880 cites W2290145688 @default.
- W3081209880 cites W2296149636 @default.
- W3081209880 cites W2396141705 @default.
- W3081209880 cites W2558925729 @default.
- W3081209880 cites W2560254877 @default.
- W3081209880 cites W2561728158 @default.
- W3081209880 cites W2757979868 @default.
- W3081209880 cites W2762858701 @default.
- W3081209880 cites W2792784918 @default.
- W3081209880 cites W2795207771 @default.
- W3081209880 cites W2806467474 @default.
- W3081209880 cites W2886124451 @default.
- W3081209880 cites W2889004478 @default.
- W3081209880 cites W2910020921 @default.
- W3081209880 cites W2925499610 @default.
- W3081209880 cites W2970411972 @default.
- W3081209880 cites W2985515336 @default.
- W3081209880 cites W2991877962 @default.
- W3081209880 cites W2997902000 @default.
- W3081209880 cites W2998547069 @default.
- W3081209880 cites W3028304854 @default.
- W3081209880 cites W4250336250 @default.
- W3081209880 doi "https://doi.org/10.3390/cancers12092363" @default.
- W3081209880 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7564912" @default.
- W3081209880 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32825566" @default.
- W3081209880 hasPublicationYear "2020" @default.
- W3081209880 type Work @default.
- W3081209880 sameAs 3081209880 @default.
- W3081209880 citedByCount "7" @default.
- W3081209880 countsByYear W30812098802020 @default.
- W3081209880 countsByYear W30812098802021 @default.
- W3081209880 countsByYear W30812098802022 @default.
- W3081209880 crossrefType "journal-article" @default.
- W3081209880 hasAuthorship W3081209880A5000050616 @default.
- W3081209880 hasAuthorship W3081209880A5023127914 @default.
- W3081209880 hasAuthorship W3081209880A5023771868 @default.
- W3081209880 hasAuthorship W3081209880A5026036097 @default.
- W3081209880 hasAuthorship W3081209880A5032767655 @default.
- W3081209880 hasAuthorship W3081209880A5042383220 @default.
- W3081209880 hasAuthorship W3081209880A5069526351 @default.
- W3081209880 hasAuthorship W3081209880A5070789043 @default.
- W3081209880 hasAuthorship W3081209880A5070894256 @default.
- W3081209880 hasBestOaLocation W30812098801 @default.
- W3081209880 hasConcept C104317684 @default.
- W3081209880 hasConcept C121608353 @default.
- W3081209880 hasConcept C126322002 @default.
- W3081209880 hasConcept C127561419 @default.
- W3081209880 hasConcept C153911025 @default.
- W3081209880 hasConcept C173396325 @default.
- W3081209880 hasConcept C185592680 @default.
- W3081209880 hasConcept C190283241 @default.
- W3081209880 hasConcept C203522944 @default.
- W3081209880 hasConcept C25602115 @default.
- W3081209880 hasConcept C27740335 @default.
- W3081209880 hasConcept C2775975398 @default.
- W3081209880 hasConcept C2777408456 @default.
- W3081209880 hasConcept C2778367456 @default.
- W3081209880 hasConcept C31573885 @default.
- W3081209880 hasConcept C33195913 @default.